Interpretation of laboratory diagnosis and molecular surveillance of Bordetella pertussis published by Euro-pean Centre for Disease Prevention and Control
10.3760/cma.j.cn101070-20230717-00009
- VernacularTitle:欧洲疾病预防控制中心《百日咳鲍特菌的实验室诊断和分子监测》解读
- Author:
Yahong HU
1
;
Kaihu YAO
Author Information
1. 国家儿童医学中心，首都医科大学附属北京儿童医院，北京市儿科研究所微生物研究室，国家呼吸系统疾病临床医学研究中心，教育部儿科重大疾病研究重点实验室，北京 100045
- Keywords:
Bordetella pertussis;
Laboratory diagnosis;
Molecular surveillance
- From:
Chinese Journal of Applied Clinical Pediatrics
2023;38(10):755-759
- CountryChina
- Language:Chinese
-
Abstract:
Pertussis is a highly contagious acute respiratory infection.Although childhood vaccination has been widely practiced, it does not result in lifelong immunity.On December 21, 2022, aiming to meet the challenge of pertussis epidemic in the world, European Centre for Disease Prevention and Control published laboratory diagnosis and molecular surveillance of Bordetella pertussis, which describes in detail the protocols for laboratory diagnosis and molecular technology for pertussis, and it is worthwhile to study and learn from healthcare professionals and technicians engaged in the field of diagnosis and treatment of pertussis disease in China.This article introduces and interprets the main contents of the document.
